OrganiGram Holdings ( ($OGI) ) has released its Q3 earnings. Here is a breakdown of the information OrganiGram Holdings presented to its ...

Beena Goldenberg, CEO of Organigram Global, joins BNN Bloomberg to discuss the company's acquisition of Motif as their outlook for the future.

Organigram's Q3 sales rose 72% to $51.14 million, driven by Motif acquisition and global demand, with margin gains and positive cash flow expected.

OrganiGram (OGI) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.02 per share a year ago. These figures are ...

TORONTO (AP) — TORONTO (AP) — Organigram Global Inc. (OGI) on Wednesday reported a loss of $4.5 million in its fiscal third quarter. On a per-share basis, the Toronto-based company said it had a loss ...

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market ...

Analysts expect OrganiGram Holdings to report an earnings per share (EPS) of $-0.01. The announcement from OrganiGram Holdings is eagerly anticipated, with investors seeking news of surpassing ...

Trump said on Monday a decision could come within the next couple of weeks. Under the Controlled Substances Act, marijuana is ...

Organigram Global Inc. (NASDAQ:OGI), a leading Canadian cannabis producer, is accelerating its international expansion with a ...

Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint.

OG Investor Session includes presentations from Organigram Global’s senior leadership team, tours of its five state-of-the-art facilities, and a live investor Q&A session Organigram Global Inc ...

Organigram Holdings Inc. (TSX: OGI) has reported its financial results for fiscal year 2024, ending September 30, 2024, posting annual net revenue of $159.8 million, up 6% compared to $150.4 million ...